TCSAM
TEVA icon

Tyrus Capital S.A.M.’s Teva Pharmaceuticals TEVA Stock Holding History

Tyrus Capital S.A.M.’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-195,000
Closed -$10.4M – 42
2016
Q1 		$10.4M Buy
+195,000
New +$11.4M 1.78% 11
2014
Q3 		– Sell
-481,463
Closed -$25.2M – 24
2014
Q2 		$25.2M Sell
481,463
-190,287
-28% -$9.73M 3.32% 16
2014
Q1 		$35.5M Buy
671,750
+171,750
+34% +$7.94M 7.2% 7
2013
Q4 		$20M Buy
+500,000
New +$19.7M 7.64% 4

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tyrus Capital S.A.M.'s TEVA Position: Q2 2016 in Review

Tyrus Capital S.A.M. sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 195,000 shares — an estimated $10.4M sold.

Tyrus Capital S.A.M. first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $35.5M in Q1 2014. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Tyrus Capital S.A.M. reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Tyrus Capital S.A.M. sold 195,000 Teva Pharmaceuticals shares in Q2 2016, an estimated $10.4M.
  • Tyrus Capital S.A.M. first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Tyrus Capital S.A.M.'s Teva Pharmaceuticals position peaked at $35.5M in Q1 2014.
  • 813 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Tyrus Capital S.A.M.'s 13F filing for Q2 2016, filed 15 Aug 2016.